U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. For Industry
  3. FDA User Fee Programs
  4. Prescription Drug User Fee Amendments
  5. PDUFA Annual Reports and Plans
  1. Prescription Drug User Fee Amendments

PDUFA Annual Reports and Plans

The Prescription Drug User Fee Act (PDUFA) requires FDA to submit two annual reports to the President and the Congress for each fiscal year: 1) a performance report and 2) a financial report. The PDUFA performance reports present FDA’s performance in meeting annual PDUFA review and other goals. The PDUFA financial reports present information on program activities, collections, and spending.

The PDUFA IV Drug Safety Five-Year Plan communicates FDA's strategy for meeting the commitments for enhancing and modernizing the drug safety system within the context of the PDUFA IV program. The PDUFA IV Five-Year Financial Plan presents FDA’s plans for investing the resources expected under PDUFA IV by organization components and PDUFA IV categories.  

Annual Reports and Plans

Back to Top